<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <title>Our Science</title>
    <link rel="preconnect" href="https://fonts.googleapis.com" />
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin />
    <link rel="preload" href="https://fonts.googleapis.com/css2?family=Outfit:wght@100..900&display=swap" as="style"
        onload="this.onload=null;this.rel='stylesheet'" />
    <link rel="stylesheet" href="/mkcbiotherapeutics/assets/global.css" />
    <link rel="stylesheet" href="/mkcbiotherapeutics/assets/css/header.css" />
    <link rel="stylesheet" href="/mkcbiotherapeutics/assets/css/contact.css" />
    <link rel="stylesheet" href="/mkcbiotherapeutics/assets/css/footer.css" />
</head>

<body>
    <div id="header"></div>

    <div class="page_banner">
        <div class="page_banner-container container__sidemargin container__maxwidth container__center">
            <div class="page_banner-title">
                <h1>Our Science</h1>
            </div>
            <div class="page_banner-absolute">
                <img src="/mkcbiotherapeutics/assets/images/commonbanner/banner_abs_image.png" />
            </div>
        </div>
    </div>

    <div class="our_science_page-section1 container__sidemargin container__maxwidth container__center">
        <div class="about__mkc--image">
            <img src="/mkcbiotherapeutics/assets/images/our-science/our science.png" alt="About MKC" loading="lazy" />
        </div>
        <div class="about__mkc--texts">
            <div class="about__mkc--para">
                <p class="text_justify">
                    We are in-licensing IP and Technology for our first regenerative medicine portfolio which has led to
                    approval of commercially marketed therapeutics in India for three different indications:
                    Osteo-Arthritis (OA) of the knee; and Critical Limb Ischemia due to Buerger’s Disease and
                    Atherosclerotic peripheral arterial disease. Our technology licensing partner has recently completed
                    randomized blinded phase 3 trial for a fourth indication of Diabetic Foot Ulcers at Plantar location
                    and is currently unblinding / analyzing the data. All four products are derived from a robust,
                    scalable, pooled allogeneic bone-marrow derived Mesenchymal Stromal Cell (MSC) therapy platform.
                    Pooling overcomes limitation of Product made from individual donors, resulting in homogeneous
                    characteristics with ability to expand in prolonged culture while maintaining trilineage
                    differentiation potential resulting in manufacture of significantly larger number of Doses from
                    single starting GMP cell bank; with said Drug Product having desired potency, as measured by strong
                    immuno-modulatory bioactivity and broad cytokine / growth factors secretion profile, and thereby
                    resulting in durable clinically-meaningful efficacy outcomes. The Drug Product is hypothesized to
                    work via mechanisms of immunomodulation of disease environment to halt / reverse progression of
                    disease and create a quasi-niche to facilitate regeneration of lost / damaged cells & tissues.
                </p>
            </div>
        </div>
    </div>

    <div class="our_science_page-tabsection">
        <div id="tab-section-1" class="tabs">
            <div class="our_science_pageTabBtn-container">
                <div
                    class="our_science_pagetab-btns tab-buttons container__sidemargin container__maxwidth container__center">
                    <button class="tab-button active" data-tab="panel-1-1">
                        <span class="font-weight-500 font-17">Regenerative Medicine</span>
                        <svg xmlns="http://www.w3.org/2000/svg" width="17" height="17" viewBox="0 0 17 17" fill="none">
                            <g clip-path="url(#clip0_590_295)">
                                <path d="M0.967773 1.92676L15.678 16.0241" stroke="#FD7401" />
                                <path d="M0.967489 16.0241L15.6777 16.024L15.6777 1.92676" stroke="#FD7401" />
                            </g>
                            <defs>
                                <clipPath id="clip0_590_295">
                                    <rect width="17" height="17" fill="white" />
                                </clipPath>
                            </defs>
                        </svg>
                    </button>
                    <button class="tab-button" data-tab="panel-1-2">
                        <span class="font-weight-500 font-17">Mechanism of Action</span>
                        <svg xmlns="http://www.w3.org/2000/svg" width="17" height="17" viewBox="0 0 17 17" fill="none">
                            <g clip-path="url(#clip0_590_295)">
                                <path d="M0.967773 1.92676L15.678 16.0241" stroke="#FD7401" />
                                <path d="M0.967489 16.0241L15.6777 16.024L15.6777 1.92676" stroke="#FD7401" />
                            </g>
                            <defs>
                                <clipPath id="clip0_590_295">
                                    <rect width="17" height="17" fill="white" />
                                </clipPath>
                            </defs>
                        </svg>
                    </button>
                    <button class="tab-button" data-tab="panel-1-3">
                        <span class="font-weight-500 font-17">Technology Platform</span>
                        <svg xmlns="http://www.w3.org/2000/svg" width="17" height="17" viewBox="0 0 17 17" fill="none">
                            <g clip-path="url(#clip0_590_295)">
                                <path d="M0.967773 1.92676L15.678 16.0241" stroke="#FD7401" />
                                <path d="M0.967489 16.0241L15.6777 16.024L15.6777 1.92676" stroke="#FD7401" />
                            </g>
                            <defs>
                                <clipPath id="clip0_590_295">
                                    <rect width="17" height="17" fill="white" />
                                </clipPath>
                            </defs>
                        </svg>
                    </button>
                    <button class="tab-button" data-tab="panel-1-4">
                        <span class="font-weight-500 font-17">CMC & Manufacturing</span>
                        <svg xmlns="http://www.w3.org/2000/svg" width="17" height="17" viewBox="0 0 17 17" fill="none">
                            <g clip-path="url(#clip0_590_295)">
                                <path d="M0.967773 1.92676L15.678 16.0241" stroke="#FD7401" />
                                <path d="M0.967489 16.0241L15.6777 16.024L15.6777 1.92676" stroke="#FD7401" />
                            </g>
                            <defs>
                                <clipPath id="clip0_590_295">
                                    <rect width="17" height="17" fill="white" />
                                </clipPath>
                            </defs>
                        </svg>
                    </button>
                </div>
            </div>
            <div class="tab-content container__sidemargin container__maxwidth container__center">
                <div class="tab-panel active" id="panel-1-1">
                    <div class="tabcontent">
                        <div class="tab-image">
                            <img src="/mkcbiotherapeutics/assets/images/our-science/regenarative medicine.png" />
                        </div>
                        <div class="tab-text">
                            <div class="tabtexts">
                                <div>
                                    <h2 class="color2-color">Regenerative Medicine</h2>
                                </div>
                                <div>
                                    <p>Regenerative medicine is a field of medicine that aims to replace or reboot
                                        tissues
                                        or organs damaged by disease, injury, or age.</p>
                                </div>
                            </div>
                            <div class="tabbtn">
                                <a target="_blank" href="https://en.wikipedia.org/wiki/Regenerative_medicine"
                                    class="primary-btn text_decoration_none">
                                    <span>Learn More</span>
                                    <svg xmlns="http://www.w3.org/2000/svg" width="17" height="17" viewBox="0 0 17 17"
                                        fill="none">
                                        <g clip-path="url(#clip0_590_295)">
                                            <path d="M0.967773 1.92676L15.678 16.0241" stroke="#FD7401" />
                                            <path d="M0.967489 16.0241L15.6777 16.024L15.6777 1.92676"
                                                stroke="#FD7401" />
                                        </g>
                                        <defs>
                                            <clipPath id="clip0_590_295">
                                                <rect width="17" height="17" fill="white" />
                                            </clipPath>
                                        </defs>
                                    </svg>
                                </a>
                            </div>
                        </div>
                    </div>
                </div>
                <div class="tab-panel" id="panel-1-2">
                    <div class="tabcontent">
                        <div class="tabcontent-section1">
                            <div class="tab-image">
                                <img src="/mkcbiotherapeutics/assets/images/our-science/mechanism of action.png" />
                            </div>
                            <div class="tab-text">
                                <div class="tabtexts">
                                    <div>
                                        <h2 class="color2-color">Mechanism of Action</h2>
                                    </div>
                                    <div>
                                        <p>The Drug Product is hypothesized to work via mechanisms of immunomodulation
                                            of
                                            disease environment to halt / reverse progression of disease and create a
                                            quasi-niche to facilitate regeneration of lost / damaged cells & tissues.
                                        </p>
                                    </div>
                                </div>
                                <div class="tabbtn display_none">
                                    <a href="" class="primary-btn text_decoration_none">
                                        <span>Learn More</span>
                                        <svg xmlns="http://www.w3.org/2000/svg" width="17" height="17"
                                            viewBox="0 0 17 17" fill="none">
                                            <g clip-path="url(#clip0_590_295)">
                                                <path d="M0.967773 1.92676L15.678 16.0241" stroke="#FD7401" />
                                                <path d="M0.967489 16.0241L15.6777 16.024L15.6777 1.92676"
                                                    stroke="#FD7401" />
                                            </g>
                                            <defs>
                                                <clipPath id="clip0_590_295">
                                                    <rect width="17" height="17" fill="white" />
                                                </clipPath>
                                            </defs>
                                        </svg>
                                    </a>
                                </div>
                            </div>
                        </div>
                        <div class="tabcontent-section2">
                            <div class="tab_section2-texts">
                                <div class="tab_section2-heading">
                                    <h2 class="color2-color">Mesenchymal Stromal Cells (MSC): In-licensed Platform</h2>
                                </div>
                                <div class="tab_section2-paragraph">
                                    <p class="text_justify">
                                        MSC are the in <b>vivo pharmacy</b> within the body that migrate to areas of
                                        inflammation, injury or disease and immuno-modulate the disease environment to
                                        permit repair / regeneration.<br><br>MSCs possess broad immunomodulatory
                                        properties
                                        that are displayed on any immune cell population through either cell-cell
                                        contact (Fas/FasLigand cognate interaction, programmed Death1 system; notch
                                        pathway; toll like receptors) or through the production of an array of bioactive
                                        molecules (as detailed in proximity of the lines) and extracellular vesicles
                                        that function as cargo of soluble mediators, including nucleic acids,
                                        mitochondria, growth factors, cytokines and lipids. <br><br><b>The end result is
                                            the
                                            creation of a micro-environment—called “quasi-niche”—that stimulate a
                                            phenotypic
                                            switch of the target cells.</b><br><br> In addition, engulfment of apoptotic
                                        bodies
                                        by
                                        macrophages, upon killing of MSCs from activated NK- and T-cells, results in the
                                        switch of macrophages towards a tolerogenic profile. <br><br>Taken together,
                                        these
                                        events explain why the duration of the therapeutic effects of MSCs exceeds their
                                        survival in the host.
                                    </p>
                                </div>
                            </div>
                            <div class="tab_section2-image">
                                <div class="tab_section2_img-container">
                                    <div class="tab_section2-img1">
                                        <img
                                            src="/mkcbiotherapeutics/assets/images/our-science/mechanism of action1.png" />
                                    </div>
                                    <div class="tab_section2-img2">
                                        <img
                                            src="/mkcbiotherapeutics/assets/images/our-science/mechanism of action 2.png" />
                                    </div>
                                </div>
                                <div class="tab_section2_caption-container">
                                    <p class="color-white"><b>Ref:</b> Ciccociopoppo R. et al. Developing Cell Therapies
                                        as Drug Products.
                                        Br J
                                        Pharmacol 178 (2), Jan 2021</p>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
                <div class="tab-panel" id="panel-1-3">
                    <div class="tabcontent">
                        <div class="tabcontent-section1">
                            <div class="tab-image">
                                <img src="/mkcbiotherapeutics/assets/images/our-science/technology platform.png" />
                            </div>
                            <div class="tab-text">
                                <div class="tabtexts">
                                    <div>
                                        <h2 class="color2-color">Technology Platform</h2>
                                    </div>
                                    <div>
                                        <p>Current products are derived from a robust, scalable, pooled allogeneic
                                            bone-marrow derived Mesenchymal Stromal Cell (MSC) therapy platform,
                                            in-licensed from Stempeutics.
                                        </p>
                                    </div>
                                </div>
                                <div class="tabbtn display_none">
                                    <a href="" class="primary-btn text_decoration_none">
                                        <span>Learn More</span>
                                        <svg xmlns="http://www.w3.org/2000/svg" width="17" height="17"
                                            viewBox="0 0 17 17" fill="none">
                                            <g clip-path="url(#clip0_590_295)">
                                                <path d="M0.967773 1.92676L15.678 16.0241" stroke="#FD7401" />
                                                <path d="M0.967489 16.0241L15.6777 16.024L15.6777 1.92676"
                                                    stroke="#FD7401" />
                                            </g>
                                            <defs>
                                                <clipPath id="clip0_590_295">
                                                    <rect width="17" height="17" fill="white" />
                                                </clipPath>
                                            </defs>
                                        </svg>
                                    </a>
                                </div>
                            </div>
                        </div>
                        <div class="tabcontent-section2">
                            <div class="tab_section2-texts">
                                <div class="tab_section2-heading">
                                    <h2 class="color2-color">Value-add of in-licensed Pooling Technology & IP</h2>
                                </div>
                                <div class="tab_section2-paragraph">
                                    <p class="text_justify">Stempeutics Proprietary Pooling Technology makes it
                                        best-in-Class. Stempeucel® has been demonstrated to be safe in over 350 patients
                                        across multiple clinical trials
                                    </p>
                                </div>
                            </div>
                            <div class="tab-maintext">
                                <div class="main_text-subcontainer main_text-1subcontainer">
                                    <div class="card7_container">
                                        <div class="card7-subcontainer">
                                            <p class="font-16 color3-color">Reduces Donor-donor Variability</p>
                                            <p class="font-14">Pooling of donors reduces donor-donor variability as
                                                experienced in other
                                                products. Regulatory agencies have expressed serious concerns in
                                                reproducibility when a single donor product is used.</p>
                                        </div>
                                    </div>
                                    <div class="card7_container">
                                        <div class="card7-subcontainer">
                                            <p class="font-16 color3-color">Robust Large-scale Production</p>
                                            <p class="font-14">Pooling donors allows for larger scale of production thus
                                                enabling robust large-scale production and reducing lot to lot
                                                variability.</p>
                                        </div>
                                    </div>
                                    <div class="card7_container">
                                        <div class="card7-subcontainer">
                                            <p class="font-16 color3-color">Broader Cytokines/ Growth Factor Array</p>
                                            <p class="font-14">Pooling of donors provides a larger cytokine/growth
                                                factor expression profile thus increasing the therapeutic potential.
                                                Dependency of an individual donor to provide the optimal profile is
                                                eliminated</p>
                                        </div>
                                    </div>
                                    <div class="card7_container">
                                        <div class="card7-subcontainer">
                                            <p class="font-16 color3-color">Low Cost of Production</p>
                                            <p class="font-14">Large scale production reduces cost of production with
                                                significant savings in facilities, personnel and quality control lot
                                                release tests (safety and characterization) related costs.</p>
                                        </div>
                                    </div>
                                    <div class="card7_container">
                                        <div class="card7-subcontainer">
                                            <p class="font-16 color3-color">Proprietary Patented Process</p>
                                            <p class="font-14">The unique and non-obvious benefits of pooling have led
                                                to a granted patent protecting Stempeutics' approach in 18 countries
                                                including US, EU and Japan.</p>
                                        </div>
                                    </div>
                                </div>
                                <div class="main_text-subcontainer main_text-2subcontainer">
                                    <div>
                                        <p class="text_justify">Pooling overcomes limitation of Product made from
                                            individual donors,
                                            resulting in homogeneous characteristics with ability to expand in prolonged
                                            culture while maintaining trilineage differentiation potential resulting in
                                            manufacture of significantly larger number of Doses from single starting GMP
                                            cell bank; with said Drug Product having desired potency, as measured by
                                            strong immuno-modulatory bioactivity and broad cytokine / growth factors
                                            secretion profile, and thereby resulting in durable clinically-meaningful
                                            efficacy outcomes.</p>
                                    </div>
                                    <hr>
                                    <div>
                                        <img src="/mkcbiotherapeutics/assets/images/our-science/pooling report.png" />
                                    </div>
                                    <div class="tabbtn">
                                        <a target="_blank" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11144708/"
                                            class="primary-btn text_decoration_none">
                                            <span>Learn More</span>
                                            <svg xmlns="http://www.w3.org/2000/svg" width="17" height="17"
                                                viewBox="0 0 17 17" fill="none">
                                                <g clip-path="url(#clip0_590_295)">
                                                    <path d="M0.967773 1.92676L15.678 16.0241" stroke="#FD7401" />
                                                    <path d="M0.967489 16.0241L15.6777 16.024L15.6777 1.92676"
                                                        stroke="#FD7401" />
                                                </g>
                                                <defs>
                                                    <clipPath id="clip0_590_295">
                                                        <rect width="17" height="17" fill="white" />
                                                    </clipPath>
                                                </defs>
                                            </svg>
                                        </a>
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="tabcontent-section3">
                            The patented manufacturing process of "Stempeucel®" includes a unique process of
                            multiple cell bank generation from which the Investigational Medicinal Product (IMP) is
                            produced. Unique cell seeding densities are used for the preparation of various cell
                            bank generations. The addition of growth factors to culture media at certain passage has
                            resulted in robust cell yield without compromising the quality of the MSCs. <br><br>The
                            "master
                            cell bank" or MCB is generated from individual donors comprising of mesenchymal stromal
                            cells that are fully characterized and cryopreserved. Next, cryopreserved MCB's are
                            thawed, cultured and expanded for generating a "working cell bank" or WCB. The WCB's are
                            also thoroughly characterized according to our extensive QC criteria prior to
                            cryopreservation. For Stempeucel® manufacturing, appropriate numbers of WCB vials are
                            thawed and expanded up to certain passages, harvested and characterized using a variety
                            of parameters necessary to establish the sterility, identity and potency of the product.
                        </div>
                    </div>
                </div>
                <div class=" tab-panel" id="panel-1-4">
                    <div class="tabcontent">
                        <div class="tab-image">
                            <img src="/mkcbiotherapeutics/assets/images/our-science/cmc manufacturing.png" />
                        </div>
                        <div class="tab-text">
                            <div class="tabtexts">
                                <div>
                                    <h2 class="color2-color">CMC & Manufacturing</h2>
                                </div>
                                <div>
                                    <p>We are currently engaged in discussions with Partners & GMP
                                        CDMOs to manufacture
                                        new qualified US donor derived allogeneic cell banks and
                                        representative lots of
                                        drug product and demonstrate in vitro comparability to the
                                        Drug Product from
                                        Indian Donor banks that has been used in treatment of many
                                        hundreds of patients
                                        in clinical trials and now commercially in India. This new
                                        US Donor-derived Drug
                                        Product will be used for patient treatment in US/Europe
                                        clinical trials under
                                        appropriate INDs/CTAs.</p>
                                </div>
                            </div>
                            <div class="tabbtn display_none">
                                <a href="" class="primary-btn text_decoration_none">
                                    <span>Learn More</span>
                                    <svg xmlns="http://www.w3.org/2000/svg" width="17" height="17" viewBox="0 0 17 17"
                                        fill="none">
                                        <g clip-path="url(#clip0_590_295)">
                                            <path d="M0.967773 1.92676L15.678 16.0241" stroke="#FD7401" />
                                            <path d="M0.967489 16.0241L15.6777 16.024L15.6777 1.92676"
                                                stroke="#FD7401" />
                                        </g>
                                        <defs>
                                            <clipPath id="clip0_590_295">
                                                <rect width="17" height="17" fill="white" />
                                            </clipPath>
                                        </defs>
                                    </svg>
                                </a>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>

    <div id="footer"></div>

    <script src="/mkcbiotherapeutics/assets/global.js"></script>
    <script src="/mkcbiotherapeutics/assets/js/tabs.js"></script>
    <script src=" /mkcbiotherapeutics/assets/js/favicon.js"></script>
</body>

</html>